A research team led by chemistry Prof. Paul Hergenrother and former PhD student Kristen Muñoz (PhD, '23) has developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.
